Association between serum levels of pro-metalloproteinase 1, tissue inhibitor of metalloproteinases 1 and 2 and prevalent cardiovascular disease in a population-based study.

Panayiotou, A G; Kamilari, E; Griffin, M; Tyllis, T; Georgiou, N; Bond, D; Hoppensteadt, D; Fareed, J; Nicolaides, A

Panayiotou, A G; Kamilari, E; Griffin, M; Tyllis, T; Georgiou, N; Bond, D; Hoppensteadt, D; Fareed, J; Nicolaides, A.

Affiliation

Panayiotou AG; Cyprus International Institute for Environmental and Public Health in association with the Harvard School of Public Health, Cyprus University of Technology, Limassol, Cyprus - andrie.panayiotou@cut.ac.cy.

Int Angiol ; 32(6): 599-604, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24212294

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Tissue Inhibitor of Metalloproteinase-1 / Tissue Inhibitor of Metalloproteinase-2 / Matrix Metalloproteinase 1 / Enzyme Precursors Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Int Angiol Year: 2013 Document type: Article Country of publication: Italia

Search on Google

Add to My VHL

XML

PubMed Links